Anthology
3 known investors
Anthology develops designer and hybrid genomes by decoding genomic "language" to engineer microbes that convert feedstocks such as sugars, plastics, and agricultural waste into products like chemicals, materials, and food ingredients. Its applications include producing functional proteins for healthy aging and GLP-1 companion foods, enzymes to improve animal health, and carbon-neutral bioproduction for a circular bioeconomy.